ClearBridge Investments’s Haemonetics HAE Stock Holding History

ClearBridge Investments’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,646	Closed	-$510K	–	809
2021 Q2	$510K	Buy	7,646 +624	+9%	+$44.2K	﹤0.01%	768
2021 Q1	$780K	Buy	7,022 +1,397	+25%	+$173K	﹤0.01%	711
2020 Q4	$668K	Buy	5,625 +1,918	+52%	+$206K	﹤0.01%	694
2020 Q3	$323K	Buy	+3,707	New	+$324K	﹤0.01%	738

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ClearBridge Investments's HAE Position: Q3 2021 in Review

ClearBridge Investments sold out of Haemonetics (HAE) in Q3 2021, closing a stake of 7,646 shares — an estimated $510K sold.

ClearBridge Investments first reported a position in HAE in Q3 2020 and held it in 4 quarters. The position peaked at $780K in Q1 2021. 245 funds tracked by Wall St. Rank hold HAE as of Q3 2021.

ClearBridge Investments reported no remaining Haemonetics position as of Q3 2021 after selling out during the quarter.
ClearBridge Investments sold 7,646 Haemonetics shares in Q3 2021, an estimated $510K.
ClearBridge Investments first reported a position in Haemonetics in Q3 2020 and held it in 4 quarters.
ClearBridge Investments's Haemonetics position peaked at $780K in Q1 2021.
245 funds tracked by Wall St. Rank held Haemonetics as of Q3 2021.

Based on ClearBridge Investments's 13F filing for Q3 2021, filed 12 Nov 2021.